Sodium Phenylbutyrate
CAS No. 1716-12-7
Sodium Phenylbutyrate ( Benzenebutanoic Acid; NSC 657802; TriButyrate )
Catalog No. M12616 CAS No. 1716-12-7
Sodium Phenylbutyrate is a transcriptional regulators that act by altering chromatin structure via the modulation of HDAC activity.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 34 | In Stock |
|
100MG | 49 | In Stock |
|
200MG | 78 | In Stock |
|
500MG | 130 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSodium Phenylbutyrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSodium Phenylbutyrate is a transcriptional regulators that act by altering chromatin structure via the modulation of HDAC activity.
-
DescriptionSodium Phenylbutyrate is a transcriptional regulators that act by altering chromatin structure via the modulation of HDAC activity.
-
SynonymsBenzenebutanoic Acid; NSC 657802; TriButyrate
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number1716-12-7
-
Formula Weight186.18
-
Molecular FormulaC10H11NaO2
-
Purity>98%(HPLC)
-
SolubilityWater: 30 mg/mL (161.13 mM); DMSO: 8 mg/mL (42.96 mM)
-
SMILESO=C([O-])CCCC1=CC=CC=C1.[Na+]
-
Chemical Namesodium 4-phenylbutanoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Burrage LC, et al. Mol Genet Metab. 2014 Sep-Oct;113(1-2):131-5.
molnova catalog
related products
-
T247
A potent and selective HDAC3 inhibitor with IC50 of 0.24 uM, >75-fold selectivity over HDAC1 and no activity against HDAC4/6/8.
-
FT895
FT895 (FT-895) is a potent and selective inhibitor of HDAC11 with IC50 of 3 nM.
-
ACY-241
ACY-241, also known as Citarinostat, is a potent, selective and orally available histone deacetylase (HDAC) inhibitor, with potential antineoplastic activity.